Literature DB >> 2297905

Standardization of serum fructosamine assays.

E D Schleicher1, B W Vogt.   

Abstract

We have calibrated a secondary serum protein standard by use (as primary standards) of samples of albumin and polylysine glycated with [14C]glucose in vitro, the glycation of which was assessed by radioactivity measurements and by elementary analysis for C and N. Using this standard for calibration in our improved fructosamine assay, one obtains an average fructosamine value of 247 mumol/L for nondiabetic individuals (or, in terms of total serum protein, 3.2 mumol/g)--about a tenth the value we obtained when we used the fructosamine assay of Johnson et al. (Clin Chim Acta 1983;127:87-95), standardized with desoxymorpholinofructose. In contrast, results corresponded well with the value for mean glycation of serum proteins, 3 mumol/g, determined by a furosine/HPLC method. Evidently the proposed procedure, in which a standard sharing the binding characteristics of endogenous glycated proteins is used together with our modified new fructosamine assay, leads to more realistic values for the concentrations of glycated serum proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297905

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

1.  Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients.

Authors:  Milca Asanghanwa; Frans K Gorus; Ilse Weets; Bart V der Auwera; Folefac Aminkeng; Eric Mbunwe; Patrick Goubert; Katrijn Verhaeghen; Eugene Sobngwi; Janet M Wenzlau; John C Hutton; Daniel G Pipeleers; Bart Keymeulen; Jean-Claude N Mbanya; Chris van Schravendijk
Journal:  Diabetes Res Clin Pract       Date:  2013-11-20       Impact factor: 5.602

2.  HPLC assay for serum glycated albumin.

Authors:  E Vorberg
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

3.  Alleviation of Dimethylnitrosamine-Induced Liver Injury and Fibrosis by Supplementation of Anabasis articulata Extract in Rats.

Authors:  Azza M Mohamed; Mohga S Abdalla; Maha Z Rizk; El-Sayed M E Mahdy; Abdel-Razik H Farrag; Fatma S El-Sharabasy; Hanan F Aly; Mohamed R Mohamed
Journal:  Indian J Clin Biochem       Date:  2013-06-14

Review 4.  Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes.

Authors:  Elisa Danese; Martina Montagnana; Antonio Nouvenne; Giuseppe Lippi
Journal:  J Diabetes Sci Technol       Date:  2015-01-14

5.  HPLC-free method of synthesis of isotopically labeled deoxyfructosylated peptides.

Authors:  Monika Kijewska; Michalina Zawadzka; Karolina Włodarczyk; Piotr Stefanowicz
Journal:  Anal Bioanal Chem       Date:  2022-03-22       Impact factor: 4.142

6.  Evaluation of clinical activity and safety of Daflon 500 mg in type 2 diabetic female patients.

Authors:  Sherine Maher Rizk; Nagwa Ali Sabri
Journal:  Saudi Pharm J       Date:  2009-08-07       Impact factor: 4.330

7.  White coat hyperglycaemia: disparity between diabetes clinic and home blood glucose concentrations.

Authors:  L V Campbell; S M Ashwell; M Borkman; D J Chisholm
Journal:  BMJ       Date:  1992-11-14

8.  Dietary coconut kernel protein beneficially modulates NFκB and RAGE expression in streptozotocin induced diabetes in rats.

Authors:  G Salil; R Nithya; K G Nevin; T Rajamohan
Journal:  J Food Sci Technol       Date:  2012-05-11       Impact factor: 2.701

9.  Topiramate-induced modulation of hepatic molecular mechanisms: an aspect for its anti-insulin resistant effect.

Authors:  Hanan S El-Abhar; Mona F Schaalan
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

10.  Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial.

Authors:  Michal Rein; Orly Ben-Yacov; Anastasia Godneva; Smadar Shilo; Niv Zmora; Dmitry Kolobkov; Noa Cohen-Dolev; Bat-Chen Wolf; Noa Kosower; Maya Lotan-Pompan; Adina Weinberger; Zamir Halpern; Shira Zelber-Sagi; Eran Elinav; Eran Segal
Journal:  BMC Med       Date:  2022-02-09       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.